Moreover, RA patients with sCD40L > 889 pg/mL had higher levels of IFNγ compared to those with concentrations < 889 pg/mL (Figure 6E), suggesting a potential link between higher sCD40L levels and immune activation pathways. This evidence concerns the gene CD40LG and rheumatoid arthritis.